{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:01:00Z","timestamp":1792454460412,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009101","name":"Education Department of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bioorg.2020.104106","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:49:52Z","timestamp":1594950592000},"page":"104106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Design and synthesis of pinane oxime derivatives as novel anti-influenza agents"],"prefix":"10.1016","volume":"102","author":[{"given":"Jianghong","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinge","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104106_b0005","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/nm1141","article-title":"Influenza: old and new threats","volume":"10","author":"Palese","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2020.104106_b0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza A viruses: new research developments","volume":"9","author":"Medina","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2020.104106_b0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-018-0340-z","article-title":"Current and future influenza vaccines","volume":"25","author":"Yamayoshi","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2020.104106_b0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.bioorg.2020.104106_b0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.18388\/abp.2014_1870","article-title":"Antivirals - current trends in fighting influenza","volume":"61","author":"Krol","year":"2014","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bioorg.2020.104106_b0030","unstructured":"What you should know about flu antiviral drugs, Centers for Disease Control and Prevention, 2019. https:\/\/www.cdc.gov\/flu\/treatment\/whatyoushould.htm. (Accessed 22 April 2019)."},{"key":"10.1016\/j.bioorg.2020.104106_b0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza and antiviral resistance: an overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.104106_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41564-019-0609-0","article-title":"Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets","volume":"5","author":"Imai","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bioorg.2020.104106_b0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bip.22623","article-title":"Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses","volume":"104","author":"Wang","year":"2015","journal-title":"Pept. Sci."},{"key":"10.1016\/j.bioorg.2020.104106_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.tips.2013.08.003","article-title":"Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel","volume":"34","author":"Gu","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2020.104106_b0055","first-page":"1551","article-title":"Crystal structure of the drug-resistant S31N influenza M2 proton channel","volume":"25","author":"Thomaston","year":"2016","journal-title":"Pept. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104106_b0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1021\/acs.biochem.9b00971","article-title":"X-ray Crystal structures of the influenza M2 proton channel drug-resistant V27A mutant bound to a spiro-adamantyl amine inhibitor reveal the mechanism of adamantane resistance","volume":"59","author":"Thomaston","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.104106_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104780","article-title":"Put a cork in it: Plugging the M2 viral ion channel to sink influenza","volume":"178","author":"Jalily","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2020.104106_b0070","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/jm301538e","article-title":"Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus","volume":"56","author":"Wang","year":"2013","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104106_b0075","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104106_b0080","doi-asserted-by":"crossref","first-page":"17987","DOI":"10.1021\/ja508461m","article-title":"Flipping in the pore: Discovery of dual Inhibitors that bind in different orientations to the wild-type versus the S31N mutant of the influenza A virus M2 proton channel","volume":"136","author":"Wu","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioorg.2020.104106_b0085","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/acs.jmedchem.5b01910","article-title":"Discovery of highly potent inhibitors targeting the predominant drug-resistant S31N mutant of the influenza A virus M2 proton channel","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2020.104106_b0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/mol.116.105346","article-title":"Pharmacological characterization of the spectrum of antiviral activity and genetic barrier to drug resistance of M2\u2013S31N channel blockers","volume":"90","author":"Ma","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.104106_b0095","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.jmedchem.6b01852","article-title":"Expeditious lead optimization of isoxazole-containing influenza A virus M2\u2013S31N inhibitors using the Suzuki-Miyaura cross-coupling reaction","volume":"60","author":"Li","year":"2017","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2020.104106_b0100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/acsmedchemlett.8b00336","article-title":"Structure\u2013property relationship studies of influenza A virus AM2-S31N proton channel blockers","volume":"9","author":"Hu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104106_b0105","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acs.jmedchem.7b01536","article-title":"In vitro pharmacokinetic optimizations of AM2-S31N channel blockers led to the discovery of slow-binding inhibitors with potent antiviral activity against drug-resistant influenza A viruses","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104106_b0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2018.03.002","article-title":"Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers","volume":"153","author":"Musharrafieh","year":"2018","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.bioorg.2020.104106_b0115","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/jm901664a","article-title":"Identification of hits as matrix-2 protein inhibitors through the focused screening of a small primary amine library","volume":"53","author":"Hu","year":"2010","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104106_b0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2010.10.010","article-title":"Discovery of highly potent agents against influenza A virus","volume":"46","author":"Zhao","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104106_b0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2012.09.001","article-title":"Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors","volume":"96","author":"Zhao","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2020.104106_b0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ejmech.2015.12.013","article-title":"Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus","volume":"108","author":"Dong","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2020.104106_b0135","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acs.jmedchem.8b00042","article-title":"Discovery of highly potent pinanamine-based inhibitors against amantadine- and oseltamivir-resistant influenza A viruses","volume":"61","author":"Zhao","year":"2018","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2020.104106_b0140","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/jm500598u","article-title":"Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A","volume":"57","author":"Kolocouris","year":"2014","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2020.104106_b0145","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/ml500108s","article-title":"Azapropellanes with anti-influenza A virus activity","volume":"5","author":"Torres","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104106_b0150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1039\/C4MD00515E","article-title":"Identification of camphor derivatives as novel M2 ion channel inhibitors of influenza A virus","volume":"6","author":"Zhao","year":"2015","journal-title":"Med. Chem. Comm."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104106_b0155","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1021\/jo00008a057","article-title":"Use of N, N'-dimethoxy-N, N'-dimethylurea as a carbonyl dication equivalent in organometallic addition reactions. Synthesis of unsymmetrical ketones","volume":"56","author":"Whipple","year":"1991","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.104106_b0160","first-page":"US5061704","volume":"use","author":"Wierzbicki","year":"1991","journal-title":"Thiophene compounds, compositions and"},{"issue":"28","key":"10.1016\/j.bioorg.2020.104106_b0165","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.tetlet.2008.05.023","article-title":"A short-cut from 1-acetyl adamantane to 2-(1-adamantyl)pyrroles","volume":"49","author":"Trofimov","year":"2008","journal-title":"Tetrahedron Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104106_b0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/jo01136a018","article-title":"Reduction of oximes with lithium aluminum hydride","volume":"17","author":"Smith","year":"1952","journal-title":"J. Org. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104106_b0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hlca.200490000","article-title":"Enantioselective synthesis of 2-(2-arylcyclopropyl)glycines: Conformationally restricted homophenylalanine analogs","volume":"87","author":"Demir","year":"2004","journal-title":"Helv. Chim. Acta"},{"issue":"21","key":"10.1016\/j.bioorg.2020.104106_b0180","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1021\/acs.jmedchem.8b01453","article-title":"Halogens in protein\u2013ligand binding mechanism: A structural perspective","volume":"62","author":"Shinada","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104106_b0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/ml100297w","article-title":"Exploring the requirements for the hydrophobic scaffold and polar amine in inhibitors of M2 from influenza A virus","volume":"2","author":"Wang","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"28","key":"10.1016\/j.bioorg.2020.104106_b0190","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.2174\/13816128113199990001","article-title":"New strategy for high throughput screening of anti-influenza virus M2 ion channel inhibitors","volume":"19","author":"Li","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104106_b0195","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2020.104106_b0200","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104106_b0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/acs.jcim.6b00628","article-title":"The underestimated halogen bonds forming with protein side chains in drug discovery and design","volume":"57","author":"Zhang","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"7281","key":"10.1016\/j.bioorg.2020.104106_b0210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature08722","article-title":"Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers","volume":"463","author":"Cady","year":"2010","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820314036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820314036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:09:29Z","timestamp":1758614969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820314036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"alternative-id":["S0045206820314036"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104106","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of pinane oxime derivatives as novel anti-influenza agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104106"}}